Female Infertility Due to Diminished Ovarian Reserve
10
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
30%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Impact of Day 2 Versus Day 3 Fresh Embryo Transfer on Live Birth Rate in Poor-Prognosis Patients
Antagonist Protocol in Poor Responders
Effect of Testosterone Treatment on Embryo Quality
Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF
Differences in Ovarian Reserve Markers and Vitamin D Between Infertile Indian, Arabian and Caucasian Population
Cohort Study to Evaluate Ovarian Function
IVF/ICSI Protocols in Poor Responders With Growth Hormone
Microflare Protocol in Poor Responders
Vitamin D Influence on Oocyte Donation
Use of Dehydroepiandrosterone (DHEA) in Women With Normal and Poor Ovarian Reserve Undergoing IVF